Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
28
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Kogan Elona Esq. | Sr. V. P. - General Counsel | 6 | $0 | $0 | 2017-02-16 |
| Gansler Jayne M. | Senior V.P. Human Resources | 6 | $0 | $0 | 2017-02-16 |
| Herron Jennifer Lyn | Exec V.P. Chief Comm'l Officer | 5 | $0 | $0 | 2017-02-16 |
| Panayiotopoulos Paris | President and CEO | 13 | $500.0K | $0 | 2017-02-16 |
| Cole Hugh M | SVP, Chief Business Officer | 29 | $0 | $42.4K | 2017-02-16 |
| Schlesinger Sarah J. | Director | 29 | $92.2K | $0 | 2017-02-16 |
| Soni Manmeet Singh | EVP, CFO & Treasurer | 5 | $0 | $0 | 2017-02-16 |
| Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | 118 | $0 | $3.79M | 2017-02-16 |
| DENNER ALEXANDER J | Director | 21 | $38111.13B | $0 | 2017-02-16 |
| Protopapas Anna | Director | 10 | $0 | $0 | 2017-02-16 |
| Haimovitz Jules | Director | 7 | $0 | $0 | 2017-02-16 |
| Bickerstaff George | Director | 7 | $0 | $0 | 2017-02-16 |
| CLACKSON TIMOTHY P | President, R&D, CSO | 163 | $0 | $11.80M | 2017-02-16 |
| RIEDEL NORBERT G | Director | 17 | $0 | $0 | 2017-02-16 |
| LAVIDAS ATHANESE | Director | 32 | $0 | $1.89M | 2016-06-15 |
| Radaelli Massimo | Director | 23 | $0 | $896.1K | 2016-06-14 |
| Cantor Maria E | SVP, Corporate Affairs and HR | 97 | $0 | $1.96M | 2016-04-29 |
| Haluska Frank | SVP, Clinical R&D, CMO | 85 | $0 | $1.37M | 2016-04-29 |
| Duvall Martin J | SVP, Commercial Operations | 55 | $0 | $346.2K | 2016-04-29 |
| FITZGERALD EDWARD M | Executive VP, CFO | 93 | $0 | $4.86M | 2016-03-21 |
| BERSTEIN DAVID L | Senior VP, Chief IP Officer | 129 | $0 | $5.63M | 2016-03-21 |
| DesRosier Thomas | EVP, General Counsel | 7 | $0 | $0 | 2016-03-07 |
| LAMARCHE JAY R | Director | 24 | $0 | $1.10M | 2016-02-01 |
| WILSON WAYNE | Director | 8 | $0 | $0 | 2016-02-01 |
| BERGER HARVEY J M D | Chairman & CEO | 125 | $1.08M | $12.23M | 2015-12-31 |
| Whelan, Jr. Robert M. | Director | 6 | $0 | $0 | 2014-01-31 |
| DODION PIERRE F | SVP, Corp. Dev. & Operations | 54 | $0 | $3.14M | 2013-11-22 |
| Keane Raymond T | SVP General Counsel & CCO | 42 | $0 | $1.96M | 2013-07-18 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| DENNER ALEXANDER J | Director | D To issuer deriv | 2017-02-16 | 2017-02-16 | 75,000 | — | $0 | 0 | SEC↗ |
| DENNER ALEXANDER J | Director | D To issuer deriv | 2017-02-16 | 2017-02-16 | 25,000 | — | $0 | 0 | SEC↗ |
| DENNER ALEXANDER J | Director | D To issuer deriv | 2017-02-16 | 2017-02-16 | 25,000 | — | $0 | 0 | SEC↗ |
| DENNER ALEXANDER J | Director | D To issuer deriv | 2017-02-16 | 2017-02-16 | 3,459,280 | — | $0 | 0 | SEC↗ |
| DENNER ALEXANDER J | Director | D To issuer deriv | 2017-02-16 | 2017-02-16 | 25,000 | — | $0 | 0 | SEC↗ |
| DENNER ALEXANDER J | Director | D To issuer deriv | 2017-02-16 | 2017-02-16 | 5,340,720 | — | $0 | 0 | SEC↗ |
| Kogan Elona Esq. | Sr. V. P. - General Counsel | D To issuer deriv | 2017-02-16 | 2017-02-16 | 200,000 | — | $0 | 0 | SEC↗ |
| Kogan Elona Esq. | Sr. V. P. - General Counsel | D To issuer deriv | 2017-02-16 | 2017-02-16 | 100,000 | — | $0 | 0 | SEC↗ |
| Kogan Elona Esq. | Sr. V. P. - General Counsel | D To issuer deriv | 2017-02-16 | 2017-02-16 | 6,085 | — | $0 | 0 | SEC↗ |
| Soni Manmeet Singh | EVP, CFO & Treasurer | D To issuer deriv | 2017-02-16 | 2017-02-16 | 7,937 | — | $0 | 0 | SEC↗ |
| Soni Manmeet Singh | EVP, CFO & Treasurer | D To issuer deriv | 2017-02-16 | 2017-02-16 | 550,000 | — | $0 | 0 | SEC↗ |
| Protopapas Anna | Director | D To issuer deriv | 2017-02-16 | 2017-02-16 | 75,000 | — | $0 | 0 | SEC↗ |
| Protopapas Anna | Director | D To issuer deriv | 2017-02-16 | 2017-02-16 | 25,000 | — | $0 | 0 | SEC↗ |
| Protopapas Anna | Director | D To issuer deriv | 2017-02-16 | 2017-02-16 | 25,000 | — | $0 | 0 | SEC↗ |
| Panayiotopoulos Paris | President and CEO | D To issuer deriv | 2017-02-16 | 2017-02-16 | 1,500,000 | — | $0 | 0 | SEC↗ |
| Panayiotopoulos Paris | President and CEO | D To issuer deriv | 2017-02-16 | 2017-02-16 | 66,800 | — | $0 | 0 | SEC↗ |
| Bollag Daniel M | Sr. VP, Reg. Affairs & Quali | D To issuer deriv | 2017-02-16 | 2017-02-16 | 60,000 | — | $0 | 0 | SEC↗ |
| Bollag Daniel M | Sr. VP, Reg. Affairs & Quali | D To issuer deriv | 2017-02-16 | 2017-02-16 | 48,000 | — | $0 | 0 | SEC↗ |
| Bollag Daniel M | Sr. VP, Reg. Affairs & Quali | D To issuer deriv | 2017-02-16 | 2017-02-16 | 52,666 | — | $0 | 0 | SEC↗ |
| Bollag Daniel M | Sr. VP, Reg. Affairs & Quali | D To issuer deriv | 2017-02-16 | 2017-02-16 | 3,439 | — | $0 | 0 | SEC↗ |
| Bollag Daniel M | Sr. VP, Reg. Affairs & Quali | D To issuer deriv | 2017-02-16 | 2017-02-16 | 38,000 | — | $0 | 0 | SEC↗ |
| RIEDEL NORBERT G | Director | D To issuer deriv | 2017-02-16 | 2017-02-16 | 25,000 | — | $0 | 0 | SEC↗ |
| RIEDEL NORBERT G | Director | D To issuer deriv | 2017-02-16 | 2017-02-16 | 25,000 | — | $0 | 0 | SEC↗ |
| RIEDEL NORBERT G | Director | D To issuer deriv | 2017-02-16 | 2017-02-16 | 25,000 | — | $0 | 0 | SEC↗ |
| RIEDEL NORBERT G | Director | D To issuer deriv | 2017-02-16 | 2017-02-16 | 25,000 | — | $0 | 0 | SEC↗ |
| RIEDEL NORBERT G | Director | D To issuer deriv | 2017-02-16 | 2017-02-16 | 25,000 | — | $0 | 0 | SEC↗ |
| Gansler Jayne M. | Senior V.P. Human Resources | D To issuer deriv | 2017-02-16 | 2017-02-16 | 72,000 | — | $0 | 0 | SEC↗ |
| Gansler Jayne M. | Senior V.P. Human Resources | D To issuer deriv | 2017-02-16 | 2017-02-16 | 144,000 | — | $0 | 0 | SEC↗ |
| Gansler Jayne M. | Senior V.P. Human Resources | D To issuer deriv | 2017-02-16 | 2017-02-16 | 2,910 | — | $0 | 0 | SEC↗ |
| Cole Hugh M | SVP, Chief Business Officer | D To issuer deriv | 2017-02-16 | 2017-02-16 | 78,000 | — | $0 | 0 | SEC↗ |
| Cole Hugh M | SVP, Chief Business Officer | D To issuer deriv | 2017-02-16 | 2017-02-16 | 100,000 | — | $0 | 0 | SEC↗ |
| Cole Hugh M | SVP, Chief Business Officer | D To issuer deriv | 2017-02-16 | 2017-02-16 | 64,733 | — | $0 | 0 | SEC↗ |
| Cole Hugh M | SVP, Chief Business Officer | D To issuer deriv | 2017-02-16 | 2017-02-16 | 9,788 | — | $0 | 0 | SEC↗ |
| Herron Jennifer Lyn | Exec V.P. Chief Comm'l Offic | D To issuer deriv | 2017-02-16 | 2017-02-16 | 5,291 | — | $0 | 0 | SEC↗ |
| Herron Jennifer Lyn | Exec V.P. Chief Comm'l Offic | D To issuer deriv | 2017-02-16 | 2017-02-16 | 300,000 | — | $0 | 0 | SEC↗ |
| Bickerstaff George | Director | D To issuer deriv | 2017-02-16 | 2017-02-16 | 25,000 | — | $0 | 0 | SEC↗ |
| Bickerstaff George | Director | D To issuer deriv | 2017-02-16 | 2017-02-16 | 75,000 | — | $0 | 0 | SEC↗ |
| Haimovitz Jules | Director | D To issuer deriv | 2017-02-16 | 2017-02-16 | 75,000 | — | $0 | 0 | SEC↗ |
| Haimovitz Jules | Director | D To issuer deriv | 2017-02-16 | 2017-02-16 | 25,000 | — | $0 | 0 | SEC↗ |
| CLACKSON TIMOTHY P | President, R&D, CSO | D To issuer deriv | 2017-02-16 | 2017-02-16 | 14,550 | — | $0 | 0 | SEC↗ |
| CLACKSON TIMOTHY P | President, R&D, CSO | D To issuer deriv | 2017-02-16 | 2017-02-16 | 82,000 | — | $0 | 0 | SEC↗ |
| CLACKSON TIMOTHY P | President, R&D, CSO | D To issuer deriv | 2017-02-16 | 2017-02-16 | 65,000 | — | $0 | 0 | SEC↗ |
| CLACKSON TIMOTHY P | President, R&D, CSO | D To issuer deriv | 2017-02-16 | 2017-02-16 | 87,125 | — | $0 | 0 | SEC↗ |
| CLACKSON TIMOTHY P | President, R&D, CSO | D To issuer deriv | 2017-02-16 | 2017-02-16 | 72,980 | — | $0 | 0 | SEC↗ |
| Schlesinger Sarah J. | Director | D To issuer deriv | 2017-02-16 | 2017-02-16 | 25,000 | — | $0 | 0 | SEC↗ |
| Schlesinger Sarah J. | Director | D To issuer deriv | 2017-02-16 | 2017-02-16 | 25,000 | — | $0 | 0 | SEC↗ |
| Schlesinger Sarah J. | Director | D To issuer deriv | 2017-02-16 | 2017-02-16 | 25,000 | — | $0 | 0 | SEC↗ |
| Schlesinger Sarah J. | Director | D To issuer deriv | 2017-02-16 | 2017-02-16 | 40,000 | — | $0 | 0 | SEC↗ |
| Schlesinger Sarah J. | Director | D To issuer deriv | 2017-02-16 | 2017-02-16 | 25,000 | — | $0 | 0 | SEC↗ |
| DENNER ALEXANDER J | Director | D To issuer | 2017-02-16 | 2017-02-16 | 53,173 | — | $0 | 0 | SEC↗ |
| DENNER ALEXANDER J | Director | D To issuer | 2017-02-16 | 2017-02-16 | 7,798,665 | — | $0 | 0 | SEC↗ |
| DENNER ALEXANDER J | Director | D To issuer | 2017-02-16 | 2017-02-16 | 5,051,335 | — | $0 | 0 | SEC↗ |
| Soni Manmeet Singh | EVP, CFO & Treasurer | D To issuer | 2017-02-16 | 2017-02-16 | 3,273 | — | $0 | 0 | SEC↗ |
| Protopapas Anna | Director | D To issuer | 2017-02-16 | 2017-02-16 | 41,910 | — | $0 | 0 | SEC↗ |
| Panayiotopoulos Paris | President and CEO | D To issuer | 2017-02-16 | 2017-02-16 | 159,378 | — | $0 | 0 | SEC↗ |
| Bollag Daniel M | Sr. VP, Reg. Affairs & Quali | D To issuer | 2017-02-16 | 2017-02-16 | 126,352 | — | $0 | 0 | SEC↗ |
| RIEDEL NORBERT G | Director | D To issuer | 2017-02-16 | 2017-02-16 | 139,867 | — | $0 | 0 | SEC↗ |
| Cole Hugh M | SVP, Chief Business Officer | D To issuer | 2017-02-16 | 2017-02-16 | 42,834 | — | $0 | 0 | SEC↗ |
| Herron Jennifer Lyn | Exec V.P. Chief Comm'l Offic | D To issuer | 2017-02-16 | 2017-02-16 | 450 | — | $0 | 0 | SEC↗ |
| Bickerstaff George | Director | D To issuer | 2017-02-16 | 2017-02-16 | 18,008 | — | $0 | 0 | SEC↗ |
| Haimovitz Jules | Director | D To issuer | 2017-02-16 | 2017-02-16 | 18,008 | — | $0 | 0 | SEC↗ |
| CLACKSON TIMOTHY P | President, R&D, CSO | D To issuer | 2017-02-16 | 2017-02-16 | 219,867 | — | $0 | 0 | SEC↗ |
| CLACKSON TIMOTHY P | President, R&D, CSO | D To issuer | 2017-02-16 | 2017-02-16 | 577 | — | $0 | 0 | SEC↗ |
| Schlesinger Sarah J. | Director | D To issuer | 2017-02-16 | 2017-02-16 | 55,508 | — | $0 | 0 | SEC↗ |
| Schlesinger Sarah J. | Director | G Gift | 2017-02-13 | 2017-02-16 | 15,600 | — | $0 | 0 | SEC↗ |
| Herron Jennifer Lyn | Exec V.P. Chief Comm'l Offic | A Award deriv | 2017-02-06 | 2017-02-07 | 5,291 | — | $0 | 5,291 | SEC↗ |
| Gansler Jayne M. | Senior V.P. Human Resources | A Award deriv | 2017-02-06 | 2017-02-07 | 2,910 | — | $0 | 2,910 | SEC↗ |
| CLACKSON TIMOTHY P | President, R&D, CSO | A Award deriv | 2017-02-06 | 2017-02-07 | 14,550 | — | $0 | 14,550 | SEC↗ |
| Bollag Daniel M | Sr. VP, Reg. Affairs & Quali | A Award deriv | 2017-02-06 | 2017-02-07 | 3,439 | — | $0 | 3,439 | SEC↗ |
| Soni Manmeet Singh | EVP, CFO & Treasurer | A Award deriv | 2017-02-06 | 2017-02-07 | 7,937 | — | $0 | 7,937 | SEC↗ |
| Kogan Elona Esq. | Sr. V. P. - General Counsel | A Award deriv | 2017-02-06 | 2017-02-07 | 6,085 | — | $0 | 6,085 | SEC↗ |
| Cole Hugh M | SVP, Chief Business Officer | A Award deriv | 2017-02-06 | 2017-02-07 | 9,788 | — | $0 | 9,788 | SEC↗ |
| Protopapas Anna | Director | A Award deriv | 2017-01-31 | 2017-02-01 | 25,000 | $23.82 | $595.5K | 25,000 | SEC↗ |
| RIEDEL NORBERT G | Director | A Award deriv | 2017-01-31 | 2017-02-01 | 25,000 | $23.82 | $595.5K | 25,000 | SEC↗ |
| Haimovitz Jules | Director | A Award deriv | 2017-01-31 | 2017-02-01 | 25,000 | $23.82 | $595.5K | 25,000 | SEC↗ |
| Schlesinger Sarah J. | Director | A Award deriv | 2017-01-31 | 2017-02-01 | 25,000 | $23.82 | $595.5K | 25,000 | SEC↗ |
| Bickerstaff George | Director | A Award deriv | 2017-01-31 | 2017-02-01 | 25,000 | $23.82 | $595.5K | 25,000 | SEC↗ |
| DENNER ALEXANDER J | Director | A Award deriv | 2017-01-31 | 2017-02-02 | 25,000 | $23.82 | $595.5K | 25,000 | SEC↗ |
| CLACKSON TIMOTHY P | President, R&D, CSO | M Exercise deriv | 2017-01-31 | 2017-02-02 | 29,333 | — | $0 | 0 | SEC↗ |
| Bollag Daniel M | Sr. VP, Reg. Affairs & Quali | M Exercise deriv | 2017-01-31 | 2017-02-02 | 29,333 | — | $0 | 0 | SEC↗ |
| Protopapas Anna | Director | A Award | 2017-01-31 | 2017-02-01 | 5,508 | — | $0 | 29,410 | SEC↗ |
| Protopapas Anna | Director | A Award | 2017-01-31 | 2017-02-01 | 12,500 | — | $0 | 41,910 | SEC↗ |
| RIEDEL NORBERT G | Director | A Award | 2017-01-31 | 2017-02-01 | 12,500 | — | $0 | 139,867 | SEC↗ |
| RIEDEL NORBERT G | Director | A Award | 2017-01-31 | 2017-02-01 | 5,508 | — | $0 | 127,367 | SEC↗ |
| Haimovitz Jules | Director | A Award | 2017-01-31 | 2017-02-01 | 5,508 | — | $0 | 5,508 | SEC↗ |
| Haimovitz Jules | Director | A Award | 2017-01-31 | 2017-02-01 | 12,500 | — | $0 | 18,008 | SEC↗ |
| Schlesinger Sarah J. | Director | A Award | 2017-01-31 | 2017-02-01 | 12,500 | — | $0 | 55,508 | SEC↗ |
| Schlesinger Sarah J. | Director | A Award | 2017-01-31 | 2017-02-01 | 5,508 | — | $0 | 43,008 | SEC↗ |
| Bickerstaff George | Director | A Award | 2017-01-31 | 2017-02-01 | 5,508 | — | $0 | 5,508 | SEC↗ |
| Bickerstaff George | Director | A Award | 2017-01-31 | 2017-02-01 | 12,500 | — | $0 | 18,008 | SEC↗ |
| DENNER ALEXANDER J | Director | A Award | 2017-01-31 | 2017-02-02 | 12,500 | — | $0 | 53,173 | SEC↗ |
| DENNER ALEXANDER J | Director | A Award | 2017-01-31 | 2017-02-02 | 5,508 | — | $0 | 40,673 | SEC↗ |
| CLACKSON TIMOTHY P | President, R&D, CSO | F Tax w/h | 2017-01-31 | 2017-02-02 | 9,610 | $23.82 | $228.9K | 219,867 | SEC↗ |
| CLACKSON TIMOTHY P | President, R&D, CSO | M Exercise | 2017-01-31 | 2017-02-02 | 29,333 | — | $0 | 229,477 | SEC↗ |
| Bollag Daniel M | Sr. VP, Reg. Affairs & Quali | F Tax w/h | 2017-01-31 | 2017-02-02 | 14,667 | $23.81 | $349.2K | 126,352 | SEC↗ |
| Bollag Daniel M | Sr. VP, Reg. Affairs & Quali | M Exercise | 2017-01-31 | 2017-02-02 | 29,333 | — | $0 | 141,019 | SEC↗ |
| Panayiotopoulos Paris | President and CEO | F Tax w/h | 2017-01-17 | 2017-01-17 | 33,300 | $23.69 | $788.9K | 159,378 | SEC↗ |
| Panayiotopoulos Paris | President and CEO | M Exercise deriv | 2017-01-13 | 2017-01-17 | 66,600 | — | $0 | 66,800 | SEC↗ |
| Panayiotopoulos Paris | President and CEO | M Exercise | 2017-01-13 | 2017-01-17 | 66,600 | — | $0 | 192,678 | SEC↗ |
| Bollag Daniel M | Sr. VP, Reg. Affairs & Quali | M Exercise deriv | 2017-01-09 | 2017-01-10 | 32,000 | — | $0 | 0 | SEC↗ |
| Bollag Daniel M | Sr. VP, Reg. Affairs & Quali | M Exercise | 2017-01-09 | 2017-01-10 | 32,000 | $7.82 | $250.2K | 161,404 | SEC↗ |
| Bollag Daniel M | Sr. VP, Reg. Affairs & Quali | S Sale | 2017-01-09 | 2017-01-10 | 32,000 | $23.78 | $761.0K | 129,404 | SEC↗ |
| CLACKSON TIMOTHY P | President, R&D, CSO | S Sale | 2016-10-24 | 2016-10-25 | 19,638 | $9.56 | $187.7K | 197,884 | SEC↗ |
| Bollag Daniel M | Sr. VP, Reg. Affairs & Quali | S Sale | 2016-10-03 | 2016-10-05 | 47,384 | $13.46 | $637.8K | 129,404 | SEC↗ |
| CLACKSON TIMOTHY P | President, R&D, CSO | S Sale | 2016-09-28 | 2016-09-28 | 8,750 | $13.98 | $122.3K | 217,522 | SEC↗ |
| CLACKSON TIMOTHY P | President, R&D, CSO | M Exercise deriv | 2016-09-26 | 2016-09-28 | 17,500 | — | $0 | 0 | SEC↗ |
| Bollag Daniel M | Sr. VP, Reg. Affairs & Quali | M Exercise deriv | 2016-09-26 | 2016-09-28 | 10,000 | — | $0 | 0 | SEC↗ |
| CLACKSON TIMOTHY P | President, R&D, CSO | M Exercise | 2016-09-26 | 2016-09-28 | 17,500 | — | $0 | 226,272 | SEC↗ |
| Bollag Daniel M | Sr. VP, Reg. Affairs & Quali | M Exercise | 2016-09-26 | 2016-09-28 | 10,000 | — | $0 | 176,788 | SEC↗ |
| CLACKSON TIMOTHY P | President, R&D, CSO | S Sale | 2016-09-22 | 2016-09-23 | 20,000 | $13.43 | $268.6K | 208,772 | SEC↗ |
| CLACKSON TIMOTHY P | President, R&D, CSO | M Exercise deriv | 2016-09-15 | 2016-09-16 | 59,369 | — | $0 | 0 | SEC↗ |
| CLACKSON TIMOTHY P | President, R&D, CSO | S Sale | 2016-09-15 | 2016-09-16 | 59,369 | $11.73 | $696.4K | 228,772 | SEC↗ |
| CLACKSON TIMOTHY P | President, R&D, CSO | M Exercise | 2016-09-15 | 2016-09-16 | 59,369 | $7.82 | $464.3K | 288,141 | SEC↗ |
| CLACKSON TIMOTHY P | President, R&D, CSO | S Sale | 2016-08-22 | 2016-08-23 | 19,436 | $10.47 | $203.5K | 228,772 | SEC↗ |
| CLACKSON TIMOTHY P | President, R&D, CSO | M Exercise deriv | 2016-08-12 | 2016-08-15 | 25,000 | — | $0 | 0 | SEC↗ |
| CLACKSON TIMOTHY P | President, R&D, CSO | S Sale | 2016-08-12 | 2016-08-15 | 25,000 | $10.50 | $262.5K | 248,208 | SEC↗ |
| CLACKSON TIMOTHY P | President, R&D, CSO | M Exercise | 2016-08-12 | 2016-08-15 | 25,000 | $7.69 | $192.3K | 273,208 | SEC↗ |
| CLACKSON TIMOTHY P | President, R&D, CSO | S Sale | 2016-07-22 | 2016-07-25 | 18,286 | $8.11 | $148.3K | 248,208 | SEC↗ |
| Kogan Elona Esq. | Sr. V. P. - General Counsel | A Award deriv | 2016-07-15 | 2016-07-19 | 200,000 | $7.13 | $1.43M | 200,000 | SEC↗ |
| Kogan Elona Esq. | Sr. V. P. - General Counsel | A Award deriv | 2016-07-15 | 2016-07-19 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Panayiotopoulos Paris | President and CEO | M Exercise deriv | 2016-07-13 | 2016-07-14 | 66,600 | — | $0 | 133,400 | SEC↗ |
| Panayiotopoulos Paris | President and CEO | F Tax w/h | 2016-07-13 | 2016-07-14 | 28,611 | $7.14 | $204.3K | 126,078 | SEC↗ |
| Panayiotopoulos Paris | President and CEO | M Exercise | 2016-07-13 | 2016-07-14 | 66,600 | — | $0 | 154,689 | SEC↗ |
| CLACKSON TIMOTHY P | President, R&D, CSO | M Exercise deriv | 2016-07-01 | 2016-07-05 | 30,000 | $3.25 | $97.5K | 0 | SEC↗ |
| CLACKSON TIMOTHY P | President, R&D, CSO | M Exercise deriv | 2016-07-01 | 2016-07-05 | 31,422 | $4.49 | $141.1K | 0 | SEC↗ |
| CLACKSON TIMOTHY P | President, R&D, CSO | M Exercise | 2016-07-01 | 2016-07-05 | 31,422 | $4.49 | $141.1K | 297,916 | SEC↗ |
| CLACKSON TIMOTHY P | President, R&D, CSO | S Sale | 2016-07-01 | 2016-07-05 | 31,422 | $7.48 | $235.0K | 266,494 | SEC↗ |
| CLACKSON TIMOTHY P | President, R&D, CSO | M Exercise | 2016-07-01 | 2016-07-05 | 30,000 | $3.25 | $97.5K | 296,494 | SEC↗ |
| CLACKSON TIMOTHY P | President, R&D, CSO | S Sale | 2016-07-01 | 2016-07-05 | 30,000 | $7.48 | $224.4K | 266,494 | SEC↗ |
| Cole Hugh M | SVP, Chief Business Officer | S Sale | 2016-06-28 | 2016-06-29 | 6,012 | $7.05 | $42.4K | 29,916 | SEC↗ |
| Cole Hugh M | SVP, Chief Business Officer | M Exercise deriv | 2016-06-27 | 2016-06-29 | 12,500 | — | $0 | 0 | SEC↗ |
| Cole Hugh M | SVP, Chief Business Officer | M Exercise deriv | 2016-06-27 | 2016-06-29 | 6,666 | — | $0 | 6,667 | SEC↗ |
| Cole Hugh M | SVP, Chief Business Officer | M Exercise | 2016-06-27 | 2016-06-29 | 12,500 | — | $0 | 29,262 | SEC↗ |
| Cole Hugh M | SVP, Chief Business Officer | M Exercise | 2016-06-27 | 2016-06-29 | 6,666 | — | $0 | 35,928 | SEC↗ |
| CLACKSON TIMOTHY P | President, R&D, CSO | S Sale | 2016-06-22 | 2016-06-23 | 23,999 | $7.28 | $174.7K | 264,742 | SEC↗ |
| LAVIDAS ATHANESE | Director | M Exercise deriv | 2016-06-15 | 2016-06-15 | 15,000 | $7.39 | $110.8K | 0 | SEC↗ |
| LAVIDAS ATHANESE | Director | M Exercise deriv | 2016-06-15 | 2016-06-15 | 25,000 | $6.45 | $161.3K | 0 | SEC↗ |
| LAVIDAS ATHANESE | Director | M Exercise deriv | 2016-06-15 | 2016-06-15 | 6,250 | $4.91 | $30.7K | 18,750 | SEC↗ |
| LAVIDAS ATHANESE | Director | M Exercise | 2016-06-15 | 2016-06-15 | 6,250 | $4.91 | $30.7K | 177,881 | SEC↗ |
| LAVIDAS ATHANESE | Director | M Exercise | 2016-06-15 | 2016-06-15 | 25,000 | $6.45 | $161.3K | 171,631 | SEC↗ |
| LAVIDAS ATHANESE | Director | M Exercise | 2016-06-15 | 2016-06-15 | 15,000 | $7.39 | $110.8K | 146,631 | SEC↗ |
| LAVIDAS ATHANESE | Director | S Sale | 2016-06-15 | 2016-06-15 | 46,250 | $8.24 | $381.1K | 131,631 | SEC↗ |
| Radaelli Massimo | Director | M Exercise deriv | 2016-06-14 | 2016-06-14 | 6,250 | $4.91 | $30.7K | 18,750 | SEC↗ |
| LAVIDAS ATHANESE | Director | M Exercise deriv | 2016-06-14 | 2016-06-15 | 10,000 | $5.49 | $54.9K | 0 | SEC↗ |
| LAVIDAS ATHANESE | Director | M Exercise deriv | 2016-06-14 | 2016-06-15 | 10,000 | $7.39 | $73.9K | 15,000 | SEC↗ |
| Radaelli Massimo | Director | S Sale | 2016-06-14 | 2016-06-14 | 6,250 | $8.13 | $50.8K | 105,500 | SEC↗ |
| Radaelli Massimo | Director | M Exercise | 2016-06-14 | 2016-06-14 | 6,250 | $4.91 | $30.7K | 111,750 | SEC↗ |
| LAVIDAS ATHANESE | Director | M Exercise | 2016-06-14 | 2016-06-15 | 10,000 | $7.39 | $73.9K | 151,631 | SEC↗ |
| LAVIDAS ATHANESE | Director | S Sale | 2016-06-14 | 2016-06-15 | 20,000 | $8.14 | $162.8K | 131,631 | SEC↗ |
| LAVIDAS ATHANESE | Director | M Exercise | 2016-06-14 | 2016-06-15 | 10,000 | $5.49 | $54.9K | 141,631 | SEC↗ |
| Radaelli Massimo | Director | M Exercise deriv | 2016-06-13 | 2016-06-14 | 27,319 | $6.38 | $174.3K | 0 | SEC↗ |
| Radaelli Massimo | Director | M Exercise deriv | 2016-06-13 | 2016-06-14 | 2,412 | $1.35 | $3.3K | 0 | SEC↗ |
| Radaelli Massimo | Director | M Exercise deriv | 2016-06-13 | 2016-06-14 | 25,000 | $6.45 | $161.3K | 0 | SEC↗ |
| Radaelli Massimo | Director | M Exercise deriv | 2016-06-13 | 2016-06-14 | 25,000 | $7.39 | $184.8K | 0 | SEC↗ |
| LAVIDAS ATHANESE | Director | M Exercise deriv | 2016-06-13 | 2016-06-15 | 10,000 | $5.49 | $54.9K | 10,000 | SEC↗ |
| Radaelli Massimo | Director | S Sale | 2016-06-13 | 2016-06-14 | 79,731 | $8.25 | $657.8K | 105,500 | SEC↗ |
| Radaelli Massimo | Director | M Exercise | 2016-06-13 | 2016-06-14 | 25,000 | $6.45 | $161.3K | 185,231 | SEC↗ |
| Radaelli Massimo | Director | M Exercise | 2016-06-13 | 2016-06-14 | 25,000 | $7.39 | $184.8K | 160,231 | SEC↗ |
| Radaelli Massimo | Director | M Exercise | 2016-06-13 | 2016-06-14 | 2,412 | $1.35 | $3.3K | 135,231 | SEC↗ |
| Radaelli Massimo | Director | M Exercise | 2016-06-13 | 2016-06-14 | 27,319 | $6.38 | $174.3K | 132,819 | SEC↗ |
| LAVIDAS ATHANESE | Director | M Exercise | 2016-06-13 | 2016-06-15 | 10,000 | $5.49 | $54.9K | 141,631 | SEC↗ |
| LAVIDAS ATHANESE | Director | S Sale | 2016-06-13 | 2016-06-15 | 10,000 | $8.21 | $82.1K | 131,631 | SEC↗ |
| Radaelli Massimo | Director | M Exercise deriv | 2016-06-10 | 2016-06-14 | 22,588 | $1.35 | $30.5K | 2,412 | SEC↗ |
| Radaelli Massimo | Director | S Sale | 2016-06-10 | 2016-06-14 | 22,588 | $8.30 | $187.5K | 105,500 | SEC↗ |
| Radaelli Massimo | Director | M Exercise | 2016-06-10 | 2016-06-14 | 22,588 | $1.35 | $30.5K | 128,088 | SEC↗ |
| Gansler Jayne M. | Senior V.P. Human Resources | A Award deriv | 2016-06-06 | 2016-06-08 | 144,000 | $8.86 | $1.28M | 144,000 | SEC↗ |
| Gansler Jayne M. | Senior V.P. Human Resources | A Award deriv | 2016-06-06 | 2016-06-08 | 72,000 | — | $0 | 72,000 | SEC↗ |
| Herron Jennifer Lyn | Exec V.P. Chief Comm'l Offic | A Award deriv | 2016-05-31 | 2016-06-01 | 300,000 | $8.85 | $2.65M | 300,000 | SEC↗ |
| CLACKSON TIMOTHY P | President, R&D, CSO | S Sale | 2016-05-23 | 2016-05-25 | 17,762 | $8.08 | $143.5K | 288,741 | SEC↗ |
| Panayiotopoulos Paris | President and CEO | P Buy | 2016-05-12 | 2016-05-13 | 26,990 | $7.41 | $200.0K | 88,089 | SEC↗ |
| Bickerstaff George | Director | A Award deriv | 2016-05-04 | 2016-05-06 | 75,000 | $6.65 | $498.8K | 75,000 | SEC↗ |
| Haimovitz Jules | Director | A Award deriv | 2016-05-04 | 2016-05-06 | 75,000 | $6.65 | $498.8K | 75,000 | SEC↗ |
| CLACKSON TIMOTHY P | President, R&D, CSO | S Sale | 2016-05-02 | 2016-05-02 | 11,700 | $7.13 | $83.4K | 306,503 | SEC↗ |
| Duvall Martin J | EVP, CCO | M Exercise deriv | 2016-04-29 | 2016-05-02 | 18,000 | — | $0 | 0 | SEC↗ |
| CLACKSON TIMOTHY P | President, R&D, CSO | M Exercise deriv | 2016-04-29 | 2016-05-02 | 23,400 | — | $0 | 0 | SEC↗ |
| Cole Hugh M | SVP, Chief Business Officer | M Exercise deriv | 2016-04-29 | 2016-05-02 | 17,334 | — | $0 | 0 | SEC↗ |
| Bollag Daniel M | Sr. VP, Reg. Affairs & Quali | M Exercise deriv | 2016-04-29 | 2016-05-02 | 17,334 | — | $0 | 0 | SEC↗ |
| Cantor Maria E | SVP, Corporate Affairs | M Exercise deriv | 2016-04-29 | 2016-05-02 | 13,334 | — | $0 | 0 | SEC↗ |
| Haluska Frank | SVP, Clinical R&D, CMO | M Exercise deriv | 2016-04-29 | 2016-05-02 | 17,334 | — | $0 | 0 | SEC↗ |
| Duvall Martin J | EVP, CCO | M Exercise | 2016-04-29 | 2016-05-02 | 18,000 | — | $0 | 111,039 | SEC↗ |
| Duvall Martin J | EVP, CCO | F Tax w/h | 2016-04-29 | 2016-05-02 | 5,850 | $7.18 | $42.0K | 105,189 | SEC↗ |
| CLACKSON TIMOTHY P | President, R&D, CSO | M Exercise | 2016-04-29 | 2016-05-02 | 23,400 | — | $0 | 318,203 | SEC↗ |
| Cole Hugh M | SVP, Chief Business Officer | F Tax w/h | 2016-04-29 | 2016-05-02 | 5,634 | $7.18 | $40.5K | 16,762 | SEC↗ |
| Cole Hugh M | SVP, Chief Business Officer | M Exercise | 2016-04-29 | 2016-05-02 | 17,334 | — | $0 | 22,396 | SEC↗ |
| Bollag Daniel M | Sr. VP, Reg. Affairs & Quali | F Tax w/h | 2016-04-29 | 2016-05-02 | 5,634 | $7.18 | $40.5K | 166,788 | SEC↗ |
| Bollag Daniel M | Sr. VP, Reg. Affairs & Quali | M Exercise | 2016-04-29 | 2016-05-02 | 17,334 | — | $0 | 172,422 | SEC↗ |
| Cantor Maria E | SVP, Corporate Affairs | M Exercise | 2016-04-29 | 2016-05-02 | 13,334 | — | $0 | 149,001 | SEC↗ |
| Cantor Maria E | SVP, Corporate Affairs | F Tax w/h | 2016-04-29 | 2016-05-02 | 4,334 | $7.18 | $31.1K | 144,667 | SEC↗ |
| Haluska Frank | SVP, Clinical R&D, CMO | M Exercise | 2016-04-29 | 2016-05-02 | 17,334 | — | $0 | 164,345 | SEC↗ |
| Haluska Frank | SVP, Clinical R&D, CMO | F Tax w/h | 2016-04-29 | 2016-05-02 | 5,634 | $7.18 | $40.5K | 158,711 | SEC↗ |
| CLACKSON TIMOTHY P | President, R&D, CSO | S Sale | 2016-04-22 | 2016-04-25 | 21,409 | $7.37 | $157.8K | 294,803 | SEC↗ |
| CLACKSON TIMOTHY P | President, R&D, CSO | S Sale | 2016-03-22 | 2016-03-23 | 23,834 | $6.58 | $156.8K | 316,212 | SEC↗ |
| Soni Manmeet Singh | EVP, CFO & Treasurer | A Award deriv | 2016-03-21 | 2016-03-22 | 550,000 | — | $0 | 550,000 | SEC↗ |
| Haluska Frank | SVP, Clinical R&D, CMO | S Sale | 2016-03-21 | 2016-03-22 | 3,575 | $6.47 | $23.1K | 147,011 | SEC↗ |
| FITZGERALD EDWARD M | Executive VP | S Sale | 2016-03-21 | 2016-03-22 | 5,417 | $6.47 | $35.0K | 320,367 | SEC↗ |
| Bollag Daniel M | Sr. VP, Reg. Affairs & Quali | S Sale | 2016-03-21 | 2016-03-22 | 4,000 | $6.47 | $25.9K | 155,088 | SEC↗ |
| BERSTEIN DAVID L | SVP, Chief IP Counsel | S Sale | 2016-03-21 | 2016-03-22 | 2,375 | $6.47 | $15.4K | 262,115 | SEC↗ |
| Haluska Frank | SVP, Clinical R&D, CMO | M Exercise deriv | 2016-03-19 | 2016-03-22 | 6,500 | — | $0 | 0 | SEC↗ |
| FITZGERALD EDWARD M | Executive VP | M Exercise deriv | 2016-03-19 | 2016-03-22 | 10,833 | — | $0 | 0 | SEC↗ |
| CLACKSON TIMOTHY P | President, R&D, CSO | M Exercise deriv | 2016-03-19 | 2016-03-22 | 10,833 | — | $0 | 0 | SEC↗ |
| Cantor Maria E | SVP, Corporate Affairs | M Exercise deriv | 2016-03-19 | 2016-03-22 | 6,500 | — | $0 | 0 | SEC↗ |
| Bollag Daniel M | Sr. VP, Reg. Affairs & Quali | M Exercise deriv | 2016-03-19 | 2016-03-22 | 8,000 | — | $0 | 0 | SEC↗ |
| BERSTEIN DAVID L | SVP, Chief IP Counsel | M Exercise deriv | 2016-03-19 | 2016-03-22 | 4,750 | — | $0 | 0 | SEC↗ |
| Duvall Martin J | EVP, CCO | M Exercise deriv | 2016-03-19 | 2016-03-22 | 8,000 | — | $0 | 0 | SEC↗ |
| Haluska Frank | SVP, Clinical R&D, CMO | M Exercise | 2016-03-19 | 2016-03-22 | 6,500 | — | $0 | 150,586 | SEC↗ |
| FITZGERALD EDWARD M | Executive VP | M Exercise | 2016-03-19 | 2016-03-22 | 10,833 | — | $0 | 325,784 | SEC↗ |
| CLACKSON TIMOTHY P | President, R&D, CSO | M Exercise | 2016-03-19 | 2016-03-22 | 10,833 | — | $0 | 345,463 | SEC↗ |
| CLACKSON TIMOTHY P | President, R&D, CSO | S Sale | 2016-03-19 | 2016-03-22 | 5,417 | $6.47 | $35.0K | 340,046 | SEC↗ |
| Cantor Maria E | SVP, Corporate Affairs | S Sale | 2016-03-19 | 2016-03-22 | 3,575 | $6.46 | $23.1K | 135,667 | SEC↗ |
| Cantor Maria E | SVP, Corporate Affairs | M Exercise | 2016-03-19 | 2016-03-22 | 6,500 | — | $0 | 139,242 | SEC↗ |
| Bollag Daniel M | Sr. VP, Reg. Affairs & Quali | M Exercise | 2016-03-19 | 2016-03-22 | 8,000 | — | $0 | 159,088 | SEC↗ |
| BERSTEIN DAVID L | SVP, Chief IP Counsel | M Exercise | 2016-03-19 | 2016-03-22 | 4,750 | — | $0 | 264,490 | SEC↗ |
| Duvall Martin J | EVP, CCO | M Exercise | 2016-03-19 | 2016-03-22 | 8,000 | — | $0 | 97,039 | SEC↗ |
| Duvall Martin J | EVP, CCO | S Sale | 2016-03-19 | 2016-03-22 | 4,000 | $6.47 | $25.9K | 93,039 | SEC↗ |
| Cole Hugh M | SVP, Chief Business Officer | M Exercise deriv | 2016-03-16 | 2016-03-18 | 7,500 | $6.21 | $46.6K | 7,500 | SEC↗ |
| Cole Hugh M | SVP, Chief Business Officer | A Award deriv | 2016-03-16 | 2016-03-18 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Cole Hugh M | SVP, Chief Business Officer | M Exercise | 2016-03-16 | 2016-03-18 | 7,500 | $6.21 | $46.6K | 7,500 | SEC↗ |
| Cole Hugh M | SVP, Chief Business Officer | F Tax w/h | 2016-03-16 | 2016-03-18 | 2,438 | $6.21 | $15.1K | 5,062 | SEC↗ |
| Bollag Daniel M | Sr. VP, Reg. Affairs & Quali | M Exercise deriv | 2016-03-15 | 2016-03-17 | 3,750 | $1.30 | $4.9K | 0 | SEC↗ |
| Bollag Daniel M | Sr. VP, Reg. Affairs & Quali | D To issuer | 2016-03-15 | 2016-03-17 | 22,814 | $6.18 | $141.0K | 132,024 | SEC↗ |
| Bollag Daniel M | Sr. VP, Reg. Affairs & Quali | M Exercise | 2016-03-15 | 2016-03-17 | 3,750 | $1.30 | $4.9K | 154,838 | SEC↗ |
| Bollag Daniel M | Sr. VP, Reg. Affairs & Quali | A Award deriv | 2016-03-07 | 2016-03-09 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Bollag Daniel M | Sr. VP, Reg. Affairs & Quali | A Award deriv | 2016-03-07 | 2016-03-09 | 18,000 | — | $0 | 18,000 | SEC↗ |
| FITZGERALD EDWARD M | Executive VP, CFO | A Award deriv | 2016-03-07 | 2016-03-09 | 26,180 | — | $0 | 26,180 | SEC↗ |
| FITZGERALD EDWARD M | Executive VP, CFO | A Award deriv | 2016-03-07 | 2016-03-09 | 87,125 | $6.51 | $567.2K | 87,125 | SEC↗ |
| Cole Hugh M | SVP, Chief Business Officer | A Award deriv | 2016-03-07 | 2016-03-09 | 78,000 | $6.51 | $507.8K | 78,000 | SEC↗ |
| Cole Hugh M | SVP, Chief Business Officer | A Award deriv | 2016-03-07 | 2016-03-09 | 23,400 | — | $0 | 23,400 | SEC↗ |
| Duvall Martin J | EVP, CCO | A Award deriv | 2016-03-07 | 2016-03-09 | 87,125 | — | $0 | 87,125 | SEC↗ |
| Duvall Martin J | EVP, CCO | A Award deriv | 2016-03-07 | 2016-03-09 | 26,180 | — | $0 | 26,180 | SEC↗ |
| DesRosier Thomas | EVP, General Counsel | A Award deriv | 2016-03-07 | 2016-03-09 | 30,800 | — | $0 | 30,800 | SEC↗ |
| DesRosier Thomas | EVP, General Counsel | A Award deriv | 2016-03-07 | 2016-03-09 | 102,500 | — | $0 | 102,500 | SEC↗ |
| CLACKSON TIMOTHY P | President, R&D, CSO | A Award deriv | 2016-03-07 | 2016-03-09 | 26,180 | — | $0 | 26,180 | SEC↗ |
| CLACKSON TIMOTHY P | President, R&D, CSO | A Award deriv | 2016-03-07 | 2016-03-09 | 87,125 | — | $0 | 87,125 | SEC↗ |
| Haluska Frank | SVP, Clinical R&D, CMO | A Award deriv | 2016-03-07 | 2016-03-09 | 18,000 | — | $0 | 18,000 | SEC↗ |
| Haluska Frank | SVP, Clinical R&D, CMO | A Award deriv | 2016-03-07 | 2016-03-09 | 60,000 | $6.51 | $390.6K | 60,000 | SEC↗ |
| Cantor Maria E | SVP, Corporate Affairs | A Award deriv | 2016-03-07 | 2016-03-09 | 51,000 | $6.51 | $332.0K | 51,000 | SEC↗ |
| Cantor Maria E | SVP, Corporate Affairs | A Award deriv | 2016-03-07 | 2016-03-09 | 15,300 | — | $0 | 15,300 | SEC↗ |
| Haluska Frank | SVP, Clinical R&D, CMO | S Sale | 2016-03-03 | 2016-03-03 | 10,588 | $6.11 | $64.7K | 144,086 | SEC↗ |
| Bollag Daniel M | Sr. VP, Reg. Affairs & Quali | S Sale | 2016-03-03 | 2016-03-03 | 9,625 | $6.11 | $58.8K | 151,088 | SEC↗ |
| CLACKSON TIMOTHY P | President, R&D, CSO | S Sale | 2016-03-03 | 2016-03-03 | 9,625 | $6.12 | $58.9K | 334,630 | SEC↗ |
| Cantor Maria E | SVP, Corporate Affairs | S Sale | 2016-03-03 | 2016-03-03 | 9,625 | $6.12 | $58.9K | 132,742 | SEC↗ |
| Duvall Martin J | EVP, CCO | S Sale | 2016-03-03 | 2016-03-03 | 9,625 | $6.12 | $58.9K | 89,039 | SEC↗ |
| BERSTEIN DAVID L | SVP, Chief IP Counsel | S Sale | 2016-03-03 | 2016-03-03 | 9,625 | $6.12 | $58.9K | 259,740 | SEC↗ |
| FITZGERALD EDWARD M | Executive VP, CFO | S Sale | 2016-03-03 | 2016-03-03 | 9,625 | $6.12 | $58.9K | 314,951 | SEC↗ |
| CLACKSON TIMOTHY P | President, R&D, CSO | S Sale | 2016-03-02 | 2016-03-03 | 25,047 | $6.00 | $150.3K | 344,255 | SEC↗ |
| Haluska Frank | SVP, Clinical R&D, CMO | M Exercise deriv | 2016-03-01 | 2016-03-03 | 19,250 | — | $0 | 19,250 | SEC↗ |
| Haluska Frank | SVP, Clinical R&D, CMO | A Award deriv | 2016-03-01 | 2016-03-03 | 38,500 | — | $0 | 38,500 | SEC↗ |
| Bollag Daniel M | Sr. VP, Reg. Affairs & Quali | A Award deriv | 2016-03-01 | 2016-03-03 | 38,500 | — | $0 | 38,500 | SEC↗ |
| Bollag Daniel M | Sr. VP, Reg. Affairs & Quali | M Exercise deriv | 2016-03-01 | 2016-03-03 | 19,250 | — | $0 | 19,250 | SEC↗ |
| CLACKSON TIMOTHY P | President, R&D, CSO | M Exercise deriv | 2016-03-01 | 2016-03-03 | 19,250 | — | $0 | 19,250 | SEC↗ |
| CLACKSON TIMOTHY P | President, R&D, CSO | A Award deriv | 2016-03-01 | 2016-03-03 | 38,500 | — | $0 | 38,500 | SEC↗ |
| Cantor Maria E | SVP, Corporate Affairs | A Award deriv | 2016-03-01 | 2016-03-03 | 38,500 | — | $0 | 38,500 | SEC↗ |
| Cantor Maria E | SVP, Corporate Affairs | M Exercise deriv | 2016-03-01 | 2016-03-03 | 19,250 | — | $0 | 19,250 | SEC↗ |
| Duvall Martin J | EVP, CCO | M Exercise deriv | 2016-03-01 | 2016-03-03 | 19,250 | — | $0 | 19,250 | SEC↗ |
| Duvall Martin J | EVP, CCO | A Award deriv | 2016-03-01 | 2016-03-03 | 38,500 | — | $0 | 38,500 | SEC↗ |
| BERSTEIN DAVID L | SVP, Chief IP Counsel | A Award deriv | 2016-03-01 | 2016-03-03 | 38,500 | — | $0 | 38,500 | SEC↗ |
| BERSTEIN DAVID L | SVP, Chief IP Counsel | M Exercise deriv | 2016-03-01 | 2016-03-03 | 19,250 | — | $0 | 19,250 | SEC↗ |
| FITZGERALD EDWARD M | Executive VP, CFO | M Exercise deriv | 2016-03-01 | 2016-03-03 | 19,250 | — | $0 | 19,250 | SEC↗ |
| FITZGERALD EDWARD M | Executive VP, CFO | A Award deriv | 2016-03-01 | 2016-03-03 | 38,500 | — | $0 | 38,500 | SEC↗ |
| Haluska Frank | SVP, Clinical R&D, CMO | M Exercise | 2016-03-01 | 2016-03-03 | 19,250 | — | $0 | 154,674 | SEC↗ |
| Bollag Daniel M | Sr. VP, Reg. Affairs & Quali | M Exercise | 2016-03-01 | 2016-03-03 | 19,250 | — | $0 | 160,713 | SEC↗ |
| CLACKSON TIMOTHY P | President, R&D, CSO | M Exercise | 2016-03-01 | 2016-03-03 | 19,250 | — | $0 | 369,302 | SEC↗ |
| Cantor Maria E | SVP, Corporate Affairs | M Exercise | 2016-03-01 | 2016-03-03 | 19,250 | — | $0 | 142,367 | SEC↗ |
| Duvall Martin J | EVP, CCO | M Exercise | 2016-03-01 | 2016-03-03 | 19,250 | — | $0 | 98,664 | SEC↗ |
| BERSTEIN DAVID L | SVP, Chief IP Counsel | M Exercise | 2016-03-01 | 2016-03-03 | 19,250 | — | $0 | 269,365 | SEC↗ |
| FITZGERALD EDWARD M | Executive VP, CFO | M Exercise | 2016-03-01 | 2016-03-03 | 19,250 | — | $0 | 324,576 | SEC↗ |
| DesRosier Thomas | EVP, General Counsel | M Exercise deriv | 2016-02-18 | 2016-03-30 | 55,000 | — | $0 | 55,000 | SEC↗ |
| DesRosier Thomas | EVP, General Counsel | M Exercise | 2016-02-18 | 2016-03-30 | 55,000 | — | $0 | 55,000 | SEC↗ |
| DesRosier Thomas | EVP, General Counsel | F Tax w/h | 2016-02-18 | 2016-03-30 | 18,370 | $5.03 | $92.4K | 36,630 | SEC↗ |
| Cantor Maria E | SVP, Corporate Affairs | M Exercise deriv | 2016-02-01 | 2016-02-03 | 29,333 | — | $0 | 29,333 | SEC↗ |
| FITZGERALD EDWARD M | Executive VP, CFO | M Exercise deriv | 2016-02-01 | 2016-02-03 | 29,333 | — | $0 | 29,333 | SEC↗ |
| BERSTEIN DAVID L | SVP, Chief IP Counsel | M Exercise deriv | 2016-02-01 | 2016-02-03 | 29,333 | — | $0 | 29,333 | SEC↗ |
| Haluska Frank | SVP, Clinical R&D, CMO | M Exercise deriv | 2016-02-01 | 2016-02-03 | 29,333 | — | $0 | 29,333 | SEC↗ |
| Bollag Daniel M | Sr. VP, Reg. Affairs & Quali | M Exercise deriv | 2016-02-01 | 2016-02-03 | 29,333 | — | $0 | 29,333 | SEC↗ |
| CLACKSON TIMOTHY P | President, R&D, CSO | M Exercise deriv | 2016-02-01 | 2016-02-03 | 29,333 | — | $0 | 29,333 | SEC↗ |
| Duvall Martin J | EVP, CCO | M Exercise deriv | 2016-02-01 | 2016-02-03 | 29,333 | — | $0 | 29,333 | SEC↗ |
| RIEDEL NORBERT G | Director | A Award deriv | 2016-02-01 | 2016-02-03 | 25,000 | $4.91 | $122.8K | 25,000 | SEC↗ |
| Schlesinger Sarah J. | Director | A Award deriv | 2016-02-01 | 2016-02-03 | 25,000 | $4.91 | $122.8K | 25,000 | SEC↗ |
| Radaelli Massimo | Director | A Award deriv | 2016-02-01 | 2016-02-03 | 25,000 | $4.91 | $122.8K | 25,000 | SEC↗ |
| Protopapas Anna | Director | A Award deriv | 2016-02-01 | 2016-02-03 | 25,000 | $4.91 | $122.8K | 25,000 | SEC↗ |
| LAVIDAS ATHANESE | Director | A Award deriv | 2016-02-01 | 2016-02-03 | 25,000 | $4.91 | $122.8K | 25,000 | SEC↗ |
| WILSON WAYNE | Director | A Award deriv | 2016-02-01 | 2016-02-03 | 25,000 | $4.91 | $122.8K | 25,000 | SEC↗ |
| LAMARCHE JAY R | Director | A Award deriv | 2016-02-01 | 2016-02-03 | 25,000 | $4.91 | $122.8K | 25,000 | SEC↗ |
| DENNER ALEXANDER J | Director | A Award deriv | 2016-02-01 | 2016-02-03 | 25,000 | $4.91 | $122.8K | 25,000 | SEC↗ |
| LAMARCHE JAY R | Director | A Award deriv | 2016-02-01 | 2016-02-09 | 25,000 | $4.91 | $122.8K | 25,000 | SEC↗ |
| Cantor Maria E | SVP, Corporate Affairs | S Sale | 2016-02-01 | 2016-02-03 | 14,667 | $4.81 | $70.5K | 123,117 | SEC↗ |
| Cantor Maria E | SVP, Corporate Affairs | M Exercise | 2016-02-01 | 2016-02-03 | 29,333 | — | $0 | 139,250 | SEC↗ |
| Cantor Maria E | SVP, Corporate Affairs | S Sale | 2016-02-01 | 2016-02-03 | 1,466 | $4.93 | $7.2K | 137,784 | SEC↗ |
| FITZGERALD EDWARD M | Executive VP, CFO | M Exercise | 2016-02-01 | 2016-02-03 | 29,333 | — | $0 | 319,993 | SEC↗ |
| FITZGERALD EDWARD M | Executive VP, CFO | S Sale | 2016-02-01 | 2016-02-03 | 14,667 | $4.81 | $70.5K | 305,326 | SEC↗ |
| BERSTEIN DAVID L | SVP, Chief IP Counsel | S Sale | 2016-02-01 | 2016-02-03 | 14,667 | $4.81 | $70.5K | 250,115 | SEC↗ |
| BERSTEIN DAVID L | SVP, Chief IP Counsel | M Exercise | 2016-02-01 | 2016-02-03 | 29,333 | — | $0 | 264,782 | SEC↗ |
| Haluska Frank | SVP, Clinical R&D, CMO | M Exercise | 2016-02-01 | 2016-02-03 | 29,333 | — | $0 | 151,557 | SEC↗ |
| Haluska Frank | SVP, Clinical R&D, CMO | S Sale | 2016-02-01 | 2016-02-03 | 16,133 | $4.81 | $77.6K | 135,424 | SEC↗ |
| Bollag Daniel M | Sr. VP, Reg. Affairs & Quali | S Sale | 2016-02-01 | 2016-02-03 | 14,667 | $4.81 | $70.5K | 141,463 | SEC↗ |
| Bollag Daniel M | Sr. VP, Reg. Affairs & Quali | M Exercise | 2016-02-01 | 2016-02-03 | 29,333 | — | $0 | 156,130 | SEC↗ |
| CLACKSON TIMOTHY P | President, R&D, CSO | S Sale | 2016-02-01 | 2016-02-03 | 14,667 | $4.81 | $70.5K | 350,052 | SEC↗ |
| CLACKSON TIMOTHY P | President, R&D, CSO | M Exercise | 2016-02-01 | 2016-02-03 | 29,333 | — | $0 | 364,719 | SEC↗ |
| Duvall Martin J | EVP, CCO | M Exercise | 2016-02-01 | 2016-02-03 | 29,333 | — | $0 | 94,081 | SEC↗ |
| Duvall Martin J | EVP, CCO | S Sale | 2016-02-01 | 2016-02-03 | 14,667 | $4.81 | $70.5K | 79,414 | SEC↗ |